Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Nature Medicine explores the latest translation and clinical research news, with results from a phase 2 clinical trial of zilebesiran from Alnylam and Roche.
Nature Medicine explores the latest translation and clinical research news, with results from a clinical trial of Novartis' discontinued gene therapy to restore fetal hemoglobin.
Nature Medicine explores the latest translation and clinical research news, with two separate groups announcing that genetically modified pig kidneys are functional in brain-dead human hosts.
Nature Medicine explores the latest translational and clinical research news, with early results from a phase 3 clinical trial of the GLP-1 receptor agonist semaglutide.
Nature Medicine explores the latest translation and clinical research news, with a phase 3 trial from Merck and Moderna testing mRNA-4157 combined with pembrolizumab in melanoma.
Nature Medicine explores the latest translational and clinical research news, with a fast-track designation for a vaccine against sexually transmitted infection with Neisseriagonorrhoeae.
Nature Medicine explores the latest translational and clinical research news, with a newly approved JAK and TEC inhibitor for the autoimmune disease alopecia areata.
Nature Medicine explores the latest translational and clinical research news, with positive efficacy and safety data from Sanofi’s treatment for autoimmune disease.
Nature Medicine explores the latest translational and clinical research news, with results from a small expansion cohort of the phase 2b SYMMETRY trial in patients with type 2 diabetes and non-alcoholic steatohepatitis.
Nature Medicine explores the latest translational and clinical research news, with a delayed FDA decision on Sarepta’s adeno-associated virus gene therapy SRP-9001.
Nature Medicine explores the latest translational and clinical research news, with FDA approval of Seres’ orally administered pill SER-109 for the treatment of recurrent Clostridioidesdifficile infection.
Nature Medicine explores the latest translational and clinical research news, with positive results from two trials of Sanofi's small interfering RNA fitusiran.
Nature Medicine explores the latest translational and clinical research news, with a New Drug Application from Sage Therapeutics and Biogen for their GABA receptor agonist.
Nature Medicine explores the latest translational and clinical research news, with Heartseed and Novo Nordisk’s clinical trial of iPSC–derived cardiomyocytes for the treatment of heart failure.
Nature Medicine explores the latest translational and clinical research news, with a monoclonal antibody that blocks the transfer of maternal immunoglobulins in pregnancy.
Nature Medicine explores the latest translational and clinical research news, with Moderna’s clinical trial of a vaccine against respiratory syncytial virus in older adults.
Nature Medicine explores the latest translational and clinical research news, with data from an ongoing clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma.
Nature Medicine explores the latest translational and clinical research news, with an immunotherapy that delays the onset of type 1 diabetes in high-risk children and adults.
